Autres langues Spectral AI, Inc.

Actions

MDAI

US84757T1051

Equipement et technologie médicale avancés

Marché Fermé - Nasdaq 22:00:00 02/10/2026			Varia. 5j.	Varia. 1 janv.
1,660 ^USD	0,00%		+4,40%	+16,90%

01/10	Spectral AI annonce la réalisation de la première visite d’initiation du centre pour l’étude clinique du système DeepView, dans le cadre de sa stratégie d’extension de l’indication aux brûlures de la tête, des mains et des pieds	CI
24/09	Spectral AI, Inc. annonce une prochaine présentation lors de l’ACS Clinical Congress 2026 consacrée à l’utilisation de l’intelligence artificielle et de l’imagerie multispectrale dans l’évaluation des plaies de brûlure	CI

Autres langues

01/10	Spectral AI Announces First Site Initiation Visit for DeepView System™ Clinical Study Supporting Label Expansion Strategy to Burns of the Head, Hands, and Feet
01/10	Spectral AI Announces Completion of First Site Initiation Visit for DeepView System Clinical Study Supporting Label Expansion Strategy to Burns of The Head, Hands, and Feet
24/09	Spectral AI Announces Upcoming Presentation at ACS Clinical Congress 2026 Highlighting the Use of Artificial Intelligence and Multi-Spectral Imaging in the Assessment of Burn Wounds
24/09	Spectral Ai, Inc. Announces Upcoming Presentation At ACS Clinical Congress 2026 Highlighting the Use of Artificial Intelligence and Multi-Spectral Imaging in the Assessment of Burn Wounds
16/09	Spectral AI Showcases DeepView® System for Burn Indication and KOL Research at Southern Regional Burn Conference
01/09	Spectral AI to Present at H.C. Wainwright 28th Annual Global Investment Conference
11/08	Spectral AI Announces 2026 Second Quarter Financial Results
11/08	Spectral Ai, Inc. Reiterates Revenue Guidance for the Year Ending December 31, 2026
11/08	Spectral AI, Inc. Reports Earnings Results for the Second Quarter and Six Months Ended June 30, 2026
29/07	Spectral AI Schedules 2026 Second Quarter Financial Results and Conference Call
08/07	Spectral Ai, Inc. Announces Appointment of Darcy Bajko to Chief Commercial Officer, Effective July 31, 2026
08/07	Spectral AI Names Darcy Bajko Chief Commercial Officer to Lead Global Sales Launch of FDA-Cleared DeepView® System for Burn Indication
29/06	Spectral AI, Inc.(NasdaqCM:MDAI) added to Russell Microcap Value Benchmark Index
29/06	Spectral AI, Inc.(NasdaqCM:MDAI) added to Russell 3000E Value Benchmark
25/06	DeepView® System Highlighted at the 2026 British Burn Association Annual Conference
12/06	Spectral AI Joins the American Board of Wound Management Foundation in Celebrating Wound Healing Awareness Month
11/06	Spectral AI to Participate in 2026 British Burn Association Annual Conference
01/06	Spectral AI Announces Voting Results of Annual Meeting of Stockholders
26/05	Spectral Ai Receives FDA De Novo Clearance for DeepView System for Burn Indication
26/05	Spectral Ai receives FDA De Novo clearance for Deepview® system for burn indication
26/05	Spectral AI Receives FDA De Novo Clearance for DeepView® System for Burn Indication
26/05	Spectral AI Receives FDA De Novo Clearance for DeepView® System for Burn Indication
12/05	Spectral AI Inc - forecasts FY2026 revenue of about $18.5 million
12/05	Spectral AI Announces 2026 First Quarter Financial Results
12/05	Spectral AI Announces 2026 First Quarter Financial Results